The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A. (2009) · Cell · doi:10.1016/j.cell.2009.03.047 · Cited by 820
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
miRecords: an integrated resource for microRNA-target interactions
Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., & Li, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn851 · Cited by 1,438
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
microRNAs exhibit high frequency genomic alterations in human cancer
Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,031
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S.-F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 948
Ueda, T., Volinia, S., Okumura, H., Shimizu, M., Taccioli, C., Rossi, S., Alder, H., Liu, C.-G., Oue, N., Yasui, W., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70343-2 · Cited by 797
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
Jeanes, A., Gottardi, C. J., & Yap, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.343 · Cited by 772
Quantification of cells cultured on 96-well plates
Kueng, W., Silber, E., & Eppenberger, U. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90710-0 · Cited by 634
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Segura, M. F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., Zakrzewski, J., Blochin, E., Rose, A., Bogunovic, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808263106 · Cited by 542
Self-citationNovel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., & Wang, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0683 · Cited by 521
Krol, J., Busskamp, V., Markiewicz, I., Stadler, M. B., Ribi, S., Richter, J., Duebel, J., Bicker, S., Fehling, H. J., Schübeler, D., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.039 · Cited by 470
Self-citationQuantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways
Bookout, A. L., & Mangelsdorf, D. J. (2003) · Nuclear Receptor Signaling · doi:10.1621/nrs.01012 · Cited by 449
The AP-2 family of transcription factors.
Eckert, D., Buhl, S., Weber, S., Jäger, R., & Schorle, H. (2005) · Genome biology · doi:10.1186/gb-2005-6-13-246 · Cited by 442
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
Neufeld, G., & Kessler, O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2404 · Cited by 404
Juan, A. H., Kumar, R. M., Marx, J. G., Young, R. A., & Sartorelli, V. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.008 · Cited by 354
Hilger-Eversheim, K., Moser, M., Schorle, H., & Buettner, R. (2000) · Gene · doi:10.1016/s0378-1119(00)00454-6 · Cited by 334
Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate
Flynt, A. S., Li, N., Thatcher, E. J., Solnica-Krezel, L., & Patton, J. G. (2007) · Nature Genetics · doi:10.1038/ng1953 · Cited by 326
Role of ADAMs in Cancer Formation and Progression
Duffy, M. J., McKiernan, E., O'Donovan, N., & McGowan, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1585 · Cited by 259
Huang, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4358 · Cited by 257
Xu, L., Shen, S. S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.-P., Wagner, S. N., Ramaswamy, S., Mesirov, J. P., & Hynes, R. O. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0344 · Cited by 254
The MET receptor tyrosine kinase in invasion and metastasis
Benvenuti, S., & Comoglio, P. M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21183 · Cited by 253
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie, S., Luca, M., Huang, S., Gutman, M., Reich, R., Johnson, J. P., & Bar‐Eli, M. (1997) · PubMed · Cited by 246
Endothelial Cell Adhesion Molecules and Cancer Progression
Kobayashi, H., Boelte, K., & Lin, P. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941032 · Cited by 244
Bosher, J. M., Williams, T., & Hurst, H. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.744 · Cited by 229
Twist-1 regulates the miR-199a/214 cluster during development
Lee, Y.-B., Bantounas, I., Lee, D.-Y., Phylactou, L., Caldwell, M. A., & Uney, J. B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn920 · Cited by 226
A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T., & Hurst, H. C. (1996) · PubMed · Cited by 225
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Segura, M. F., Belitskaya-Lévy, I., Rose, A. E., Zakrzewski, J., Gaziel, A., Hanniford, D., Darvishian, F., Berman, R. S., Shapiro, R. L., Pavlick, A. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2721 · Cited by 215
Self-citationYin, G., Chen, R., Alvero, A. B., Fu, H.-H., Holmberg, J., Glackin, C., Rutherford, T., & Mor, G. (2010) · Oncogene · doi:10.1038/onc.2010.111 · Cited by 210
Matrix-directed regulation of pericellular proteolysis and tumor progression
Hornebeck, W., Emonard, H., Monboisse, J.-C., & Bellon, G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00026-3 · Cited by 202
DOCK10-Mediated Cdc42 Activation Is Necessary for Amoeboid Invasion of Melanoma Cells
Gadea, G., Sanz-Moreno, V., Self, A., Godi, A., & Marshall, C. J. (2008) · Current Biology · doi:10.1016/j.cub.2008.08.053 · Cited by 198
Dnm3os, a non‐coding RNA, is required for normal growth and skeletal development in mice
Watanabe, T., Sato, T., Amano, T., Kawamura, Y., Kawamura, N., Kawaguchi, H., Yamashita, N., Kurihara, H., & Nakaoka, T. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21787 · Cited by 168
Worley, L. A., Long, M. D., Onken, M. D., & Harbour, J. W. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e3282feeac6 · Cited by 162
α3aβ1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins
DiPersio, C. M., Shah, S., & Hynes, R. O. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2321 · Cited by 160
MicroRNAs couple cell fate and developmental timing in retina
Decembrini, S., Bressan, D., Vignali, R., Pitto, L., Mariotti, S., Rainaldi, G., Wang, X., Evangelista, M., Barsacchi, G., & Cremisi, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909167106 · Cited by 139
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
Cruz‐Muñoz, W., & Khokha, R. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360801973244 · Cited by 137
Hynes, N. E., Taverna, D., Harwerth, I. M., Ciardiello, F., Salomon, D. S., Yamamoto, T. S., & Groner, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4027-4034.1990 · Cited by 127
Self-citationRole of miRNAs in the progression of malignant melanoma
Mueller, D., & Bosserhoff, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605204 · Cited by 114
Gene Regulation in Melanoma Progression by the AP‐2 Transcription Factor
Bar‐Eli, M. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140202.x · Cited by 113
Swart, G. W. M., Lunter, P. C., van Kilsdonk, J. W. J., & van Kempen, L. C. L. T. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1573-0 · Cited by 112
Iyer, V., Pumiglia, K. M., & DiPersio, C. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.01708 · Cited by 112
Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells
Eskandarpour, M., Kiaii, S., Zhu, C., Castro, J., Sakko, A. J., & Hansson, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20873 · Cited by 110
Longo, N., Yáñez‐Mó, M., Mittelbrunn, M., de la Rosa, G., Muñoz, M.-L., Sánchez‐Madrid, F., & Sánchez‐Mateos, P. (2001) · Blood · doi:10.1182/blood.v98.13.3717 · Cited by 110
Mitchell, K., Svenson, K. B., Longmate, W. M., Gkirtzimanaki, K., Sądej, R., Wang, X., Zhao, J., Eliopoulos, A. G., Berditchevski, F., & DiPersio, C. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4283 · Cited by 97
Essential role of PDK1 in regulating endothelial cell migration
Primo, L., di Blasio, L., Roca, C., Droetto, S., Piva, R., Schaffhausen, B. S., & Bussolino, F. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200607053 · Cited by 83
Liang, S., Sharma, A. K., Peng, H., Robertson, G. P., & Dong, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4233 · Cited by 82
MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis
Valastyan, S., & Weinberg, R. A. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9802 · Cited by 81
Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo
Gershenwald, J. E., Sumner, W. E., Calderone, T. L., Wang, Z., Huang, S., & Bar‐Eli, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204450 · Cited by 77
AP‐2α and AP‐2γ regulate tumor progression via specific genetic programs
Orso, F., Penna, E., Cimino, D., Astanina, E., Maione, F., Valdembri, D., Giraudo, E., Serini, G., Sismondi, P., Bortoli, M. D., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-106492 · Cited by 74
Self-citationBerger, A. J., Davis, D. W., Tellez, C. S., Prieto, V. G., Gershenwald, J. E., Johnson, M. M., Rimm, D. L., & Bar‐Eli, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2300 · Cited by 66
The genomic structure of the human AP-2 transcription factor
Bauer, R., Imhof, A., Pscherer, A., Kopp, H., Moser, M., Seegers, S., Kerscher, M., Tainsky, M. A., Hofstaedter, F., & Buettner, R. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.8.1413 · Cited by 59
Lázár, V., Ecsedi, S., Szöllősi, A. G., Tóth, R., Vízkeleti, L., Rákosy, Z., Bégány, Á., Ádány, R., & Balázs, M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.109 · Cited by 46
Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth
Fei, J., Lan, F., Guo, M., Li, Y., & Liu, Y. (2008) · Journal of drug targeting · doi:10.1080/10611860802295946 · Cited by 34
Circosta, P., Granziero, L., Follenzi, A., Vigna, E., Stella, S., Vallario, A., Elia, A. R., Gammaitoni, L., Vitaggio, K., Orso, F., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.117 · Cited by 34
Self-citation
Cited by
Anoikis: an emerging hallmark in health and diseases
Taddei, M., Giannoni, E., Fiaschi, T., & Chiarugi, P. (2012) · The Journal of Pathology · doi:10.1002/path.3000 · Cited by 716
The integrin adhesome: from genes and proteins to human disease
Winograd-Katz, S. E., Fässler, R., Geiger, B., & Legate, K. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3769 · Cited by 623
miR-214 targets ATF4 to inhibit bone formation
Wang, X., Guo, B., Li, Q., Peng, J., Yang, Z., Wang, A., Li, D., Hou, Z., Lv, K., Kan, G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3026 · Cited by 559
van Balkom, B. W. M., de Jong, O. G., Smits, M., Brummelman, J., den Ouden, K., de Bree, P. M., van Eijndhoven, M. A. J., Pegtel, D. M., Stoorvogel, W., Würdinger, T., et al. (2013) · Blood · doi:10.1182/blood-2013-02-478925 · Cited by 515
Sohel, M. M. H., Hoelker, M., Noferesti, S. S., Salilew-Wondim, D., Tholen, E., Looft, C., Rings, F., Uddin, M. J., Spencer, T. E., Schellander, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078505 · Cited by 333
Metadata
- Authors
- Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella‐Abate, S., De Pittà, C., Pinatel, E., Stadler, M. B., Provero, P., Bernengo, M. G., Osman, I., & Taverna, D.
- Venue
- The EMBO Journal
- Published
- 2011-04-05
- Volume
- 30
- Issue
- 10
- Pages
- 1990-2007
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2098302826
- Cited by
- 261
- References
- 70
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.